Bayer Aktiengesellschaft (VIE:BAYN)

Market Cap	44.47B +115.7%
Revenue (ttm)	45.87B -1.9%
Net Income	-198.00M
EPS	-0.20
Shares Out	n/a
PE Ratio	n/a
Forward PE	9.07
Dividend	0.11 (0.25%)
Ex-Dividend Date	Apr 28, 2025

Volume	2,563
Average Volume	3,413
Open	44.43
Previous Close	44.35
Day's Range	44.20 - 44.80
52-Week Range	18.66 - 46.64
Beta	n/a
RSI	66.40
Earnings Date	Feb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 88,502
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BAYN

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.